Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Therapeutic Radioisotopes market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Therapeutic Radioisotopes market. Detailed analysis of key players, along with key growth strategies adopted by Therapeutic Radioisotopes industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
International Isotopes
Novartis
Jubilant DraxImage
Spectrum Pharmaceuticals
Lantheus
Q BioMed
Dongcheng
Progenics Pharmaceuticals
China Isotope & Radiation
Curium Pharmaceuticals
Bayer
By Type:
Radium-223
Lutetium-177
Iodine-131
Other
By End-User:
Thyroid
Bone Metastasis
Lymphoma
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Therapeutic Radioisotopes Market
-
1.3 Market Segment by Type
-
1.3.1 China Therapeutic Radioisotopes Market Size and Growth Rate of Radium-223 from 2016 to 2027
-
1.3.2 China Therapeutic Radioisotopes Market Size and Growth Rate of Lutetium-177 from 2016 to 2027
-
1.3.3 China Therapeutic Radioisotopes Market Size and Growth Rate of Iodine-131 from 2016 to 2027
-
1.3.4 China Therapeutic Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Therapeutic Radioisotopes Market Size and Growth Rate of Thyroid from 2016 to 2027
-
1.4.2 China Therapeutic Radioisotopes Market Size and Growth Rate of Bone Metastasis from 2016 to 2027
-
1.4.3 China Therapeutic Radioisotopes Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
1.4.4 China Therapeutic Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Therapeutic Radioisotopes Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Therapeutic Radioisotopes by Major Types
-
3.4.1 Market Size and Growth Rate of Radium-223
-
3.4.2 Market Size and Growth Rate of Lutetium-177
-
3.4.3 Market Size and Growth Rate of Iodine-131
-
3.4.4 Market Size and Growth Rate of Other
4 Segmentation of Therapeutic Radioisotopes Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Therapeutic Radioisotopes by Major End-Users
-
4.4.1 Market Size and Growth Rate of Therapeutic Radioisotopes in Thyroid
-
4.4.2 Market Size and Growth Rate of Therapeutic Radioisotopes in Bone Metastasis
-
4.4.3 Market Size and Growth Rate of Therapeutic Radioisotopes in Lymphoma
-
4.4.4 Market Size and Growth Rate of Therapeutic Radioisotopes in Other
5 Market Analysis by Regions
-
5.1 China Therapeutic Radioisotopes Production Analysis by Regions
-
5.2 China Therapeutic Radioisotopes Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Therapeutic Radioisotopes Landscape Analysis
-
6.1 North China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
6.2 North China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
7 Central China Therapeutic Radioisotopes Landscape Analysis
-
7.1 Central China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
7.2 Central China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
8 South China Therapeutic Radioisotopes Landscape Analysis
-
8.1 South China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
8.2 South China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
9 East China Therapeutic Radioisotopes Landscape Analysis
-
9.1 East China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
9.2 East China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
10 Northeast China Therapeutic Radioisotopes Landscape Analysis
-
10.1 Northeast China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
10.2 Northeast China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
11 Southwest China Therapeutic Radioisotopes Landscape Analysis
-
11.1 Southwest China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
11.2 Southwest China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
12 Northwest China Therapeutic Radioisotopes Landscape Analysis
-
12.1 Northwest China Therapeutic Radioisotopes Landscape Analysis by Major Types
-
12.2 Northwest China Therapeutic Radioisotopes Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 International Isotopes
-
13.1.1 International Isotopes Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis
-
13.2.1 Novartis Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Jubilant DraxImage
-
13.3.1 Jubilant DraxImage Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Spectrum Pharmaceuticals
-
13.4.1 Spectrum Pharmaceuticals Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Lantheus
-
13.5.1 Lantheus Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Q BioMed
-
13.6.1 Q BioMed Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Dongcheng
-
13.7.1 Dongcheng Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Progenics Pharmaceuticals
-
13.8.1 Progenics Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 China Isotope & Radiation
-
13.9.1 China Isotope & Radiation Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Curium Pharmaceuticals
-
13.10.1 Curium Pharmaceuticals Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Bayer
-
13.11.1 Bayer Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Radium-223 from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Lutetium-177 from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Iodine-131 from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Thyroid from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Bone Metastasis from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
Figure China Therapeutic Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Therapeutic Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Therapeutic Radioisotopes Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Therapeutic Radioisotopes
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Therapeutic Radioisotopes by Different Types from 2016 to 2027
-
Table Consumption Share of Therapeutic Radioisotopes by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Radium-223
-
Figure Market Size and Growth Rate of Lutetium-177
-
Figure Market Size and Growth Rate of Iodine-131
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Therapeutic Radioisotopes by Different End-Users from 2016 to 2027
-
Table Consumption Share of Therapeutic Radioisotopes by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Thyroid
-
Figure Market Size and Growth Rate of Bone Metastasis
-
Figure Market Size and Growth Rate of Lymphoma
-
Figure Market Size and Growth Rate of Other
-
Table China Therapeutic Radioisotopes Production by Regions
-
Table China Therapeutic Radioisotopes Production Share by Regions
-
Figure China Therapeutic Radioisotopes Production Share by Regions in 2016
-
Figure China Therapeutic Radioisotopes Production Share by Regions in 2021
-
Figure China Therapeutic Radioisotopes Production Share by Regions in 2027
-
Table China Therapeutic Radioisotopes Consumption by Regions
-
Table China Therapeutic Radioisotopes Consumption Share by Regions
-
Figure China Therapeutic Radioisotopes Consumption Share by Regions in 2016
-
Figure China Therapeutic Radioisotopes Consumption Share by Regions in 2021
-
Figure China Therapeutic Radioisotopes Consumption Share by Regions in 2027
-
Table North China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table North China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure North China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure North China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure North China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table North China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table North China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure North China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure North China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure North China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table Central China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table Central China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Central China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure Central China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure Central China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table Central China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Central China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure Central China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure Central China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table South China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table South China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure South China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure South China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure South China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table South China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table South China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure South China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure South China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure South China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table East China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table East China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure East China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure East China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure East China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table East China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table East China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure East China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure East China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure East China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table Northeast China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table Northeast China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table Northeast China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Northeast China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure Northeast China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table Southwest China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table Southwest China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table Southwest China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Southwest China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure Southwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table Northwest China Therapeutic Radioisotopes Consumption by Types from 2016 to 2027
-
Table Northwest China Therapeutic Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by Types in 2016
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by Types in 2021
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by Types in 2027
-
Table Northwest China Therapeutic Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Northwest China Therapeutic Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2016
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2021
-
Figure Northwest China Therapeutic Radioisotopes Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of International Isotopes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of International Isotopes
-
Figure Sales and Growth Rate Analysis of International Isotopes
-
Figure Revenue and Market Share Analysis of International Isotopes
-
Table Product and Service Introduction of International Isotopes
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Jubilant DraxImage
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant DraxImage
-
Figure Sales and Growth Rate Analysis of Jubilant DraxImage
-
Figure Revenue and Market Share Analysis of Jubilant DraxImage
-
Table Product and Service Introduction of Jubilant DraxImage
-
Table Company Profile and Development Status of Spectrum Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals
-
Table Product and Service Introduction of Spectrum Pharmaceuticals
-
Table Company Profile and Development Status of Lantheus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus
-
Figure Sales and Growth Rate Analysis of Lantheus
-
Figure Revenue and Market Share Analysis of Lantheus
-
Table Product and Service Introduction of Lantheus
-
Table Company Profile and Development Status of Q BioMed
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Q BioMed
-
Figure Sales and Growth Rate Analysis of Q BioMed
-
Figure Revenue and Market Share Analysis of Q BioMed
-
Table Product and Service Introduction of Q BioMed
-
Table Company Profile and Development Status of Dongcheng
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng
-
Figure Sales and Growth Rate Analysis of Dongcheng
-
Figure Revenue and Market Share Analysis of Dongcheng
-
Table Product and Service Introduction of Dongcheng
-
Table Company Profile and Development Status of Progenics Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals
-
Table Product and Service Introduction of Progenics Pharmaceuticals
-
Table Company Profile and Development Status of China Isotope & Radiation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation
-
Figure Sales and Growth Rate Analysis of China Isotope & Radiation
-
Figure Revenue and Market Share Analysis of China Isotope & Radiation
-
Table Product and Service Introduction of China Isotope & Radiation
-
Table Company Profile and Development Status of Curium Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Curium Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Curium Pharmaceuticals
-
Table Product and Service Introduction of Curium Pharmaceuticals
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
